| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Integrated Screen, Part 1
Test Code16148
CPT Codes
Refer to Maternal Serum Integrated Screen, Part 2 (test code 16150) <br><br><strong>Not for California Clients. </strong><br><strong>For New York patient testing, use test 16976.</strong>
Includes
This test will be reported and billed with Maternal Serum Integrated Screen, Part 2 results.
Preferred Specimen
1.5 mL serum
Minimum Volume
0.8 mL
Instructions
Collect between 9.0 weeks to 13 6/7 weeks.
Perform between 9.0 weeks and 13.9 weeks gestational age. A special Maternal Serum Screen requisition designed to obtain patient data and the patients informed consent must be utilized when ordering this test, because these results are influenced by certain patient characteristics. All data requested on the requisition form must be complete to permit accurate interpretation of results.
Perform between 9.0 weeks and 13.9 weeks gestational age. A special Maternal Serum Screen requisition designed to obtain patient data and the patients informed consent must be utilized when ordering this test, because these results are influenced by certain patient characteristics. All data requested on the requisition form must be complete to permit accurate interpretation of results.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 28 days
Refrigerated: 14 days
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Moderate hemolysis • Gross hemolysis • Lipemia
Methodology
Chemiluminescence (CL) • Immunoassay (IA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 6 days a week.
Report Available
Reports in 3 to 5 days.
Limitations
Refer to Integrated Screen, Part 2 (test code 16150).
Clinical Significance
To assess maternal risk for carrying a fetus with Down Syndrome (Trisomy 21), Trisomy 18, or a neural tube defect. These types of tests are standard-of-care in obstetrics.
